Despite regulatory headwinds and a 52-week low, the creator is buying HIMS, believing in its long-term disruption potential in healthcare and its growth in other segments.
Source Post
Hims stock is at a major conviction test for me. Ive experienced extreme low-sentiment phases with volatile...
KevvonzFeb 9, 2026
The creator discusses HIMS & Hers Health Inc. ($HIMS) in the context of recent regulatory actions by the FDA and Department of Justice regarding their weight loss drug offerings. Despite the legal risks and the stock's 52-week low, the creator maintains a bullish stance, believing in the company's long-term disruption potential in healthcare, drawing parallels to early Amazon and Netflix. They acknowledge the risks but are backing their vision due to the company's growth in other areas like peptides and cancer detection, and the current price levels.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
HIMS
buy opened Feb 9, 2026
+38.75%